|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/64 | |
| G01N 33/50 | |||
| C12Q 1/37 |
| (11) | Number of the document | 2683816 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12707625.5 |
| Date of filing the European patent application | 2012-03-09 | |
| (97) | Date of publication of the European application | 2014-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2012/054143 |
| Date | 2012-03-09 |
| (87) | Number | WO 2012/123370 |
| Date | 2012-09-20 |
| (30) | Number | Date | Country code |
| 201161464982 P | 2011-03-11 | US | |
| 11157812 | 2011-03-11 | EP |
| (72) |
FINK, Klaus, DE
VEY, Martin, US
|
| (73) |
Merz Pharma GmbH & Co. KGaA,
Eckenheimer Landstrasse 100, 60318 Frankfurt am Main,
DE
|
| (54) | METHOD FOR THE DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITY |
| METHOD FOR THE DETERMINATION OF BOTULINUM NEUROTOXIN BIOLOGICAL ACTIVITY |